Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selexipag in pulmonary arterial hypertension
NCT01106014Phase 3Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Dec 2009
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 39
01
Overview
A Phase 3 trial of selexipag in pulmonary arterial hypertension (PAH), sponsored by Actelion Pharmaceuticals Ltd. Started Dec 2009; status: completed.
02
Drugs
selexipag
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT01106014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01106014.